Optimizing HFrEF Survival by Early Initiation of All Guideline-Directed Medical Therapies

For Preventing Events after TAVI in Patients with Atrial Fibrillation, NOAC Is a Viable Option

ETNA-AF Registry: All Atrial Fibrillation Subgroups, Even the Old and Frail, Are Included in NOAC Benefit

New Data Emphasize Prompt Initiation of ARNI Therapy as a Standard of Care for HFrEF in Patients With and Without Diabetes

ARIADNE Real-World Study: Confirming Outcomes and Wellbeing of Patients with Chronic Heart Failure

Major Trials Alter Standards for Anticoagulant Therapy in PAD and Valve Replacement

Large Heart Failure Studies Challenge Definition of Reduced Heart Failure

THEMIS-PCI: Potent Dual Antiplatelet Regimen Found Beneficial in Diabetic Patients with CAD and History of PCI

For Stroke Prevention in Patients with Atrial Fibrillation Undergoing PCI, Double Antiplatelet Therapy Found to be Safe

Landmark DAPA-HF Trial: New Approach to Treatment of Heart Failure

Clarifying the Heart Failure Story: Data from PARAGON-HF, EVALUATE-HF, and PROVE-HF

SGLT-2 Inhibitor Decreases Renal Outcomes in Diabetic Patients without Baseline Renal Impairment